

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of molecule of bacterial origin (GO:0032490) | 6.40213774 |
| 2 | negative regulation of cell killing (GO:0031342) | 6.09271315 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.09271315 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.02741604 |
| 5 | central nervous system myelination (GO:0022010) | 5.96804897 |
| 6 | axon ensheathment in central nervous system (GO:0032291) | 5.96804897 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.92700191 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 5.85791268 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 5.70291314 |
| 10 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.68668535 |
| 11 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 5.57669508 |
| 12 | detection of external biotic stimulus (GO:0098581) | 5.48388242 |
| 13 | response to peptidoglycan (GO:0032494) | 5.28786751 |
| 14 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.10475274 |
| 15 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.08719442 |
| 16 | cellular extravasation (GO:0045123) | 4.99354928 |
| 17 | detection of biotic stimulus (GO:0009595) | 4.77437095 |
| 18 | response to host (GO:0075136) | 4.68353203 |
| 19 | response to host defenses (GO:0052200) | 4.68353203 |
| 20 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.68353203 |
| 21 | macrophage activation (GO:0042116) | 4.66151709 |
| 22 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.57733351 |
| 23 | leukocyte aggregation (GO:0070486) | 4.57335726 |
| 24 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.53824172 |
| 25 | negative regulation of interleukin-12 production (GO:0032695) | 4.50199291 |
| 26 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.49996807 |
| 27 | superoxide anion generation (GO:0042554) | 4.46979779 |
| 28 | phagosome maturation (GO:0090382) | 4.43464519 |
| 29 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.36968801 |
| 30 | sequestering of metal ion (GO:0051238) | 4.26801296 |
| 31 | respiratory burst (GO:0045730) | 4.25853564 |
| 32 | neutrophil activation (GO:0042119) | 4.25695026 |
| 33 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.24655367 |
| 34 | neutrophil mediated immunity (GO:0002446) | 4.22944254 |
| 35 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.21792771 |
| 36 | regulation of gamma-delta T cell activation (GO:0046643) | 4.16513715 |
| 37 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.15672183 |
| 38 | myeloid cell activation involved in immune response (GO:0002275) | 4.09107546 |
| 39 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.06825853 |
| 40 | fatty acid elongation (GO:0030497) | 4.05187376 |
| 41 | reactive oxygen species biosynthetic process (GO:1903409) | 4.01742482 |
| 42 | granulocyte activation (GO:0036230) | 3.97655300 |
| 43 | response to interleukin-15 (GO:0070672) | 3.97451178 |
| 44 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.96741730 |
| 45 | immunoglobulin mediated immune response (GO:0016064) | 3.87936003 |
| 46 | myelin maintenance (GO:0043217) | 3.77023699 |
| 47 | negative regulation of neurotransmitter transport (GO:0051589) | 3.73809717 |
| 48 | positive regulation of actin filament depolymerization (GO:0030836) | 3.73022115 |
| 49 | positive regulation of type 2 immune response (GO:0002830) | 3.71776488 |
| 50 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.71489741 |
| 51 | negative regulation of T cell mediated immunity (GO:0002710) | 3.70892708 |
| 52 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.68961327 |
| 53 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.68196526 |
| 54 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.68018919 |
| 55 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.67879994 |
| 56 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.64519735 |
| 57 | myeloid leukocyte mediated immunity (GO:0002444) | 3.64448586 |
| 58 | cellular response to interleukin-15 (GO:0071350) | 3.61782927 |
| 59 | regulation of mast cell degranulation (GO:0043304) | 3.59177866 |
| 60 | positive regulation of mast cell activation (GO:0033005) | 3.57379039 |
| 61 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.45706293 |
| 62 | B cell receptor signaling pathway (GO:0050853) | 3.44788325 |
| 63 | intracellular pH reduction (GO:0051452) | 3.41983698 |
| 64 | positive regulation of interferon-alpha production (GO:0032727) | 3.41228101 |
| 65 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.37942883 |
| 66 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.36596979 |
| 67 | chronic inflammatory response (GO:0002544) | 3.34758707 |
| 68 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.34290296 |
| 69 | T-helper 1 type immune response (GO:0042088) | 3.33837274 |
| 70 | regulation of mast cell activation (GO:0033003) | 3.33447911 |
| 71 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.32994938 |
| 72 | protein neddylation (GO:0045116) | 3.23639238 |
| 73 | dendritic cell migration (GO:0036336) | 3.23492303 |
| 74 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.23070120 |
| 75 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.23070120 |
| 76 | defense response to protozoan (GO:0042832) | 3.21532329 |
| 77 | regulation of activation of Janus kinase activity (GO:0010533) | 3.21153777 |
| 78 | B cell mediated immunity (GO:0019724) | 3.19733737 |
| 79 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.19565202 |
| 80 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.19461750 |
| 81 | negative regulation of B cell mediated immunity (GO:0002713) | 3.19461750 |
| 82 | regulation of interferon-alpha production (GO:0032647) | 3.19145488 |
| 83 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.18413541 |
| 84 | pH reduction (GO:0045851) | 3.15964508 |
| 85 | cellular response to type I interferon (GO:0071357) | 3.15251808 |
| 86 | type I interferon signaling pathway (GO:0060337) | 3.15251808 |
| 87 | myeloid leukocyte activation (GO:0002274) | 3.13110763 |
| 88 | response to type I interferon (GO:0034340) | 3.11489561 |
| 89 | negative regulation of macroautophagy (GO:0016242) | 3.10689040 |
| 90 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.10644489 |
| 91 | positive regulation of mast cell degranulation (GO:0043306) | 3.10644489 |
| 92 | regulation of B cell differentiation (GO:0045577) | 3.10394015 |
| 93 | neutrophil chemotaxis (GO:0030593) | 3.09882761 |
| 94 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.09392967 |
| 95 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.09362901 |
| 96 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 3.08433022 |
| 97 | leukocyte mediated cytotoxicity (GO:0001909) | 3.07496690 |
| 98 | regulation of leukocyte degranulation (GO:0043300) | 3.06728125 |
| 99 | myelination (GO:0042552) | 3.05686074 |
| 100 | activated T cell proliferation (GO:0050798) | 3.05664763 |
| 101 | ensheathment of neurons (GO:0007272) | 3.05658852 |
| 102 | axon ensheathment (GO:0008366) | 3.05658852 |
| 103 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.05205247 |
| 104 | negative regulation of protein localization to cell surface (GO:2000009) | 3.04228250 |
| 105 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.03544052 |
| 106 | neutrophil migration (GO:1990266) | 3.02169621 |
| 107 | dendritic cell chemotaxis (GO:0002407) | 3.01909863 |
| 108 | positive regulation of B cell differentiation (GO:0045579) | 2.98515361 |
| 109 | presynaptic membrane assembly (GO:0097105) | 2.98382701 |
| 110 | presynaptic membrane organization (GO:0097090) | 2.96647765 |
| 111 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.96066064 |
| 112 | negative regulation of exocytosis (GO:0045920) | 2.95584417 |
| 113 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.94905890 |
| 114 | negative regulation of adaptive immune response (GO:0002820) | 2.94199951 |
| 115 | regulation of tolerance induction (GO:0002643) | 2.93432058 |
| 116 | positive regulation of interferon-beta production (GO:0032728) | 2.93401488 |
| 117 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.87726819 |
| 118 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.87726819 |
| 119 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.86950100 |
| 120 | response to fungus (GO:0009620) | 2.83601324 |
| 121 | L-amino acid import (GO:0043092) | 2.79841275 |
| 122 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.78335484 |
| 123 | cholesterol biosynthetic process (GO:0006695) | 2.76894771 |
| 124 | regulation of beta-amyloid formation (GO:1902003) | 2.76661505 |
| 125 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.76299167 |
| 126 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.76299167 |
| 127 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.75569897 |
| 128 | detection of other organism (GO:0098543) | 2.71256962 |
| 129 | regulation of collateral sprouting (GO:0048670) | 2.68990083 |
| 130 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.68700641 |
| 131 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.66657660 |
| 132 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.65534532 |
| 133 | organ or tissue specific immune response (GO:0002251) | 2.64545224 |
| 134 | positive regulation of T cell migration (GO:2000406) | 2.64376221 |
| 135 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.61135150 |
| 136 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.60258740 |
| 137 | glycosylceramide metabolic process (GO:0006677) | 2.60019028 |
| 138 | detection of bacterium (GO:0016045) | 2.58361485 |
| 139 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.58074682 |
| 140 | positive regulation of lymphocyte migration (GO:2000403) | 2.55433360 |
| 141 | regulation of T-helper cell differentiation (GO:0045622) | 2.54975317 |
| 142 | microglial cell activation (GO:0001774) | 2.54694476 |
| 143 | response to host immune response (GO:0052572) | 2.54339088 |
| 144 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.54339088 |
| 145 | sterol biosynthetic process (GO:0016126) | 2.51324954 |
| 146 | nerve growth factor signaling pathway (GO:0038180) | 2.47715388 |
| 147 | cellular response to gamma radiation (GO:0071480) | 2.47351544 |
| 148 | regulation of podosome assembly (GO:0071801) | 2.46502372 |
| 149 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.46240742 |
| 150 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.46240742 |
| 151 | regulation of growth of symbiont in host (GO:0044126) | 2.46240742 |
| 152 | negative regulation of growth of symbiont in host (GO:0044130) | 2.46240742 |
| 153 | GPI anchor biosynthetic process (GO:0006506) | 2.46080711 |
| 154 | Rap protein signal transduction (GO:0032486) | 2.45695086 |
| 155 | regulation of RIG-I signaling pathway (GO:0039535) | 2.44454236 |
| 156 | regulation of T cell migration (GO:2000404) | 2.43759399 |
| 157 | regulation of chemokine biosynthetic process (GO:0045073) | 2.43384249 |
| 158 | positive regulation of heat generation (GO:0031652) | 2.42485698 |
| 159 | response to lipoprotein particle (GO:0055094) | 2.41147176 |
| 160 | positive regulation by symbiont of host defense response (GO:0052509) | 2.41143500 |
| 161 | modulation by symbiont of host defense response (GO:0052031) | 2.41143500 |
| 162 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.41143500 |
| 163 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.41143500 |
| 164 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.41143500 |
| 165 | modulation by symbiont of host immune response (GO:0052553) | 2.41143500 |
| 166 | eye photoreceptor cell differentiation (GO:0001754) | 2.38853355 |
| 167 | photoreceptor cell differentiation (GO:0046530) | 2.38853355 |
| 168 | leukotriene metabolic process (GO:0006691) | 2.38828636 |
| 169 | leukocyte degranulation (GO:0043299) | 2.38749513 |
| 170 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.38639586 |
| 171 | signal peptide processing (GO:0006465) | 2.38440134 |
| 172 | regulation of immunoglobulin secretion (GO:0051023) | 2.38400912 |
| 173 | transferrin transport (GO:0033572) | 2.37113182 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.75622190 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.38230632 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.05945504 |
| 4 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.29869387 |
| 5 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.05335490 |
| 6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.04286396 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.81776931 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.81638992 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.66202055 |
| 10 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.61041766 |
| 11 | SPI1_23127762_ChIP-Seq_K562_Human | 2.59376257 |
| 12 | MYB_26560356_Chip-Seq_TH2_Human | 2.48539124 |
| 13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.48275165 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.47550849 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.45920857 |
| 16 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.45535552 |
| 17 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.44169705 |
| 18 | VDR_22108803_ChIP-Seq_LS180_Human | 2.43660907 |
| 19 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.40979928 |
| 20 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.39249555 |
| 21 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.32630996 |
| 22 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.29213996 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.28228237 |
| 24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.27750451 |
| 25 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.25650673 |
| 26 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.16557245 |
| 27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.11009120 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.08980872 |
| 29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.07835723 |
| 30 | MYB_26560356_Chip-Seq_TH1_Human | 2.01351364 |
| 31 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.01179059 |
| 32 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.98820879 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.96829679 |
| 34 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.96243006 |
| 35 | MAF_26560356_Chip-Seq_TH1_Human | 1.89227021 |
| 36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.88839291 |
| 37 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.86430672 |
| 38 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.85557707 |
| 39 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.81782735 |
| 40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.81593481 |
| 41 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.80013170 |
| 42 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.78722135 |
| 43 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.74776831 |
| 44 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.73179088 |
| 45 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.71825543 |
| 46 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.71696039 |
| 47 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.70810645 |
| 48 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.68210504 |
| 49 | P300_19829295_ChIP-Seq_ESCs_Human | 1.67953204 |
| 50 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67424134 |
| 51 | UTX_26944678_Chip-Seq_JUKART_Human | 1.65850389 |
| 52 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.65627863 |
| 53 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.65238642 |
| 54 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.64846528 |
| 55 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.63299117 |
| 56 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.61865946 |
| 57 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.61593804 |
| 58 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.61173812 |
| 59 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.61173812 |
| 60 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.59648907 |
| 61 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.59200635 |
| 62 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.58825194 |
| 63 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.58628016 |
| 64 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.58445195 |
| 65 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.56527891 |
| 66 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.54808948 |
| 67 | GATA1_22025678_ChIP-Seq_K562_Human | 1.54554900 |
| 68 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.54317203 |
| 69 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.53993483 |
| 70 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.52905049 |
| 71 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.52138704 |
| 72 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.51819186 |
| 73 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.50685944 |
| 74 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.50226711 |
| 75 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.48907737 |
| 76 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.46878472 |
| 77 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.42009824 |
| 78 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.41870434 |
| 79 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.41617532 |
| 80 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.41074047 |
| 81 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40266411 |
| 82 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.40154161 |
| 83 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39432786 |
| 84 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.38568990 |
| 85 | * SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.38553616 |
| 86 | * PU1_27457419_Chip-Seq_LIVER_Mouse | 1.38239620 |
| 87 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.37091027 |
| 88 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.36896431 |
| 89 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36367560 |
| 90 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.36094646 |
| 91 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.35962874 |
| 92 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.35672099 |
| 93 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.35582744 |
| 94 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.34443387 |
| 95 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.34030236 |
| 96 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.32967294 |
| 97 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.32671274 |
| 98 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.31355661 |
| 99 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.31154279 |
| 100 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.30900398 |
| 101 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.29827212 |
| 102 | STAT3_23295773_ChIP-Seq_U87_Human | 1.29718490 |
| 103 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.29711051 |
| 104 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.28682344 |
| 105 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.28474723 |
| 106 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.26789051 |
| 107 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24338796 |
| 108 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.24126029 |
| 109 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23942009 |
| 110 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.23838110 |
| 111 | * CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.23106113 |
| 112 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.22113598 |
| 113 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21957752 |
| 114 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.20706965 |
| 115 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.19320762 |
| 116 | MAF_26560356_Chip-Seq_TH2_Human | 1.18863295 |
| 117 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17905561 |
| 118 | GATA3_26560356_Chip-Seq_TH2_Human | 1.17089835 |
| 119 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.12161952 |
| 120 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.12115186 |
| 121 | TCF4_23295773_ChIP-Seq_U87_Human | 1.11933866 |
| 122 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.11005564 |
| 123 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09990351 |
| 124 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.09801209 |
| 125 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.09801209 |
| 126 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.09801209 |
| 127 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.08905506 |
| 128 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07882036 |
| 129 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07800318 |
| 130 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.07344722 |
| 131 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06341599 |
| 132 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06219287 |
| 133 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.05367235 |
| 134 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03129655 |
| 135 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.03067657 |
| 136 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02455214 |
| 137 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.02267026 |
| 138 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01218539 |
| 139 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.00282676 |
| 140 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.00085703 |
| 141 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.00010910 |
| 142 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.99823600 |
| 143 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.95458502 |
| 144 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.93813180 |
| 145 | EWS_26573619_Chip-Seq_HEK293_Human | 0.93666935 |
| 146 | * KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.93547357 |
| 147 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.93081150 |
| 148 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92671297 |
| 149 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.92233963 |
| 150 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.91840599 |
| 151 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.90950199 |
| 152 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.90879978 |
| 153 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.90781402 |
| 154 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.90537859 |
| 155 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.90537859 |
| 156 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90518405 |
| 157 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.90441014 |
| 158 | GATA2_19941826_ChIP-Seq_K562_Human | 0.89365711 |
| 159 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88285818 |
| 160 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.88070673 |
| 161 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.86855123 |
| 162 | GATA1_19941826_ChIP-Seq_K562_Human | 0.85470067 |
| 163 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.84415434 |
| 164 | MYC_22102868_ChIP-Seq_BL_Human | 0.83623606 |
| 165 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.83364455 |
| 166 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.82531095 |
| 167 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80331566 |
| 168 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.79356115 |
| 169 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.78754992 |
| 170 | GATA3_26560356_Chip-Seq_TH1_Human | 0.77439197 |
| 171 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75451390 |
| 172 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.72132089 |
| 173 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.61586544 |
| 174 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.61324665 |
| 175 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.61285850 |
| 176 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.60836000 |
| 177 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.60816367 |
| 178 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.59396277 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003183_abnormal_peptide_metabolism | 3.67796380 |
| 2 | MP0006082_CNS_inflammation | 3.24555334 |
| 3 | MP0000920_abnormal_myelination | 3.14626146 |
| 4 | MP0001800_abnormal_humoral_immune | 2.83648483 |
| 5 | MP0009785_altered_susceptibility_to | 2.77398745 |
| 6 | MP0008260_abnormal_autophagy | 2.71166034 |
| 7 | MP0005171_absent_coat_pigmentation | 2.59728324 |
| 8 | MP0005310_abnormal_salivary_gland | 2.55478280 |
| 9 | MP0003950_abnormal_plasma_membrane | 2.55314653 |
| 10 | MP0003136_yellow_coat_color | 2.43920944 |
| 11 | MP0003880_abnormal_central_pattern | 2.43857477 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.34037294 |
| 13 | MP0003690_abnormal_glial_cell | 2.28652880 |
| 14 | MP0002132_abnormal_respiratory_system | 2.22530528 |
| 15 | MP0004742_abnormal_vestibular_system | 2.21177199 |
| 16 | MP0002419_abnormal_innate_immunity | 2.20169299 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.18264084 |
| 18 | MP0005058_abnormal_lysosome_morphology | 2.16442271 |
| 19 | MP0003300_gastrointestinal_ulcer | 2.07270046 |
| 20 | MP0005464_abnormal_platelet_physiology | 2.04696890 |
| 21 | MP0001986_abnormal_taste_sensitivity | 2.04133819 |
| 22 | MP0003172_abnormal_lysosome_physiology | 2.01180635 |
| 23 | MP0000569_abnormal_digit_pigmentation | 1.95591020 |
| 24 | MP0003329_amyloid_beta_deposits | 1.94957740 |
| 25 | MP0001485_abnormal_pinna_reflex | 1.91995369 |
| 26 | MP0002405_respiratory_system_inflammati | 1.91729471 |
| 27 | MP0003724_increased_susceptibility_to | 1.88973341 |
| 28 | MP0004883_abnormal_blood_vessel | 1.88257022 |
| 29 | MP0001835_abnormal_antigen_presentation | 1.85506441 |
| 30 | MP0002398_abnormal_bone_marrow | 1.85500114 |
| 31 | MP0000716_abnormal_immune_system | 1.83679140 |
| 32 | MP0003195_calcinosis | 1.81716750 |
| 33 | MP0000465_gastrointestinal_hemorrhage | 1.79182046 |
| 34 | MP0003303_peritoneal_inflammation | 1.78837553 |
| 35 | MP0001346_abnormal_lacrimal_gland | 1.76869984 |
| 36 | MP0003763_abnormal_thymus_physiology | 1.70407135 |
| 37 | MP0002735_abnormal_chemical_nociception | 1.69490717 |
| 38 | MP0005025_abnormal_response_to | 1.66586421 |
| 39 | MP0008877_abnormal_DNA_methylation | 1.63989962 |
| 40 | MP0004043_abnormal_pH_regulation | 1.61303456 |
| 41 | MP0002277_abnormal_respiratory_mucosa | 1.59830930 |
| 42 | MP0003634_abnormal_glial_cell | 1.59784499 |
| 43 | MP0004381_abnormal_hair_follicle | 1.59582170 |
| 44 | MP0002064_seizures | 1.58450650 |
| 45 | MP0000689_abnormal_spleen_morphology | 1.58213110 |
| 46 | MP0009278_abnormal_bone_marrow | 1.57120171 |
| 47 | MP0002722_abnormal_immune_system | 1.56289449 |
| 48 | MP0005451_abnormal_body_composition | 1.54585444 |
| 49 | MP0005387_immune_system_phenotype | 1.52721676 |
| 50 | MP0001790_abnormal_immune_system | 1.52721676 |
| 51 | MP0003436_decreased_susceptibility_to | 1.52087346 |
| 52 | MP0005000_abnormal_immune_tolerance | 1.51385896 |
| 53 | MP0004270_analgesia | 1.50781472 |
| 54 | MP0010155_abnormal_intestine_physiology | 1.50195083 |
| 55 | MP0002396_abnormal_hematopoietic_system | 1.47549346 |
| 56 | MP0003866_abnormal_defecation | 1.46733608 |
| 57 | MP0001501_abnormal_sleep_pattern | 1.46358026 |
| 58 | MP0005397_hematopoietic_system_phenotyp | 1.45015372 |
| 59 | MP0001545_abnormal_hematopoietic_system | 1.45015372 |
| 60 | MP0002876_abnormal_thyroid_physiology | 1.44333708 |
| 61 | MP0005671_abnormal_response_to | 1.43815226 |
| 62 | MP0002429_abnormal_blood_cell | 1.43118345 |
| 63 | MP0001440_abnormal_grooming_behavior | 1.42539238 |
| 64 | MP0004510_myositis | 1.42316743 |
| 65 | MP0000383_abnormal_hair_follicle | 1.39998373 |
| 66 | MP0005164_abnormal_response_to | 1.39733154 |
| 67 | MP0004885_abnormal_endolymph | 1.38334522 |
| 68 | MP0001529_abnormal_vocalization | 1.38215646 |
| 69 | MP0002272_abnormal_nervous_system | 1.38097931 |
| 70 | MP0009046_muscle_twitch | 1.37431269 |
| 71 | MP0003787_abnormal_imprinting | 1.35964120 |
| 72 | MP0001486_abnormal_startle_reflex | 1.34783708 |
| 73 | MP0000858_altered_metastatic_potential | 1.32641936 |
| 74 | MP0002166_altered_tumor_susceptibility | 1.31364647 |
| 75 | MP0003186_abnormal_redox_activity | 1.31348089 |
| 76 | MP0000703_abnormal_thymus_morphology | 1.31141380 |
| 77 | MP0004947_skin_inflammation | 1.28156439 |
| 78 | MP0002229_neurodegeneration | 1.27120356 |
| 79 | MP0003632_abnormal_nervous_system | 1.26468901 |
| 80 | MP0010678_abnormal_skin_adnexa | 1.24258642 |
| 81 | MP0002734_abnormal_mechanical_nocicepti | 1.23365347 |
| 82 | MP0001905_abnormal_dopamine_level | 1.22386269 |
| 83 | MP0002736_abnormal_nociception_after | 1.22238227 |
| 84 | MP0001188_hyperpigmentation | 1.20862028 |
| 85 | MP0005075_abnormal_melanosome_morpholog | 1.20268469 |
| 86 | MP0008057_abnormal_DNA_replication | 1.19615796 |
| 87 | MP0002723_abnormal_immune_serum | 1.17563639 |
| 88 | MP0000604_amyloidosis | 1.14936955 |
| 89 | MP0001851_eye_inflammation | 1.14040997 |
| 90 | MP0001970_abnormal_pain_threshold | 1.13696950 |
| 91 | MP0001533_abnormal_skeleton_physiology | 1.12258174 |
| 92 | MP0009333_abnormal_splenocyte_physiolog | 1.12213247 |
| 93 | MP0003221_abnormal_cardiomyocyte_apopto | 1.10873715 |
| 94 | MP0004782_abnormal_surfactant_physiolog | 1.09867535 |
| 95 | MP0000015_abnormal_ear_pigmentation | 1.09773923 |
| 96 | MP0003631_nervous_system_phenotype | 1.09104433 |
| 97 | MP0005410_abnormal_fertilization | 1.06872149 |
| 98 | MP0001968_abnormal_touch/_nociception | 1.05571962 |
| 99 | MP0001819_abnormal_immune_cell | 1.03478851 |
| 100 | MP0002452_abnormal_antigen_presenting | 1.02650977 |
| 101 | MP0002163_abnormal_gland_morphology | 1.02299058 |
| 102 | MP0005166_decreased_susceptibility_to | 0.99317710 |
| 103 | MP0002420_abnormal_adaptive_immunity | 0.98687761 |
| 104 | MP0002998_abnormal_bone_remodeling | 0.97133794 |
| 105 | MP0004142_abnormal_muscle_tone | 0.96021262 |
| 106 | MP0005253_abnormal_eye_physiology | 0.94076919 |
| 107 | MP0003633_abnormal_nervous_system | 0.93440173 |
| 108 | MP0001764_abnormal_homeostasis | 0.90679790 |
| 109 | * MP0001845_abnormal_inflammatory_respons | 0.89946832 |
| 110 | MP0000681_abnormal_thyroid_gland | 0.88960277 |
| 111 | MP0009745_abnormal_behavioral_response | 0.88840270 |
| 112 | MP0000778_abnormal_nervous_system | 0.88419938 |
| 113 | MP0005379_endocrine/exocrine_gland_phen | 0.87512124 |
| 114 | MP0005551_abnormal_eye_electrophysiolog | 0.87127856 |
| 115 | MP0003448_altered_tumor_morphology | 0.87107285 |
| 116 | MP0005645_abnormal_hypothalamus_physiol | 0.86652759 |
| 117 | MP0002733_abnormal_thermal_nociception | 0.86345539 |
| 118 | MP0005408_hypopigmentation | 0.85885563 |
| 119 | MP0001963_abnormal_hearing_physiology | 0.84400488 |
| 120 | MP0009764_decreased_sensitivity_to | 0.84378660 |
| 121 | MP0003656_abnormal_erythrocyte_physiolo | 0.84073302 |
| 122 | MP0003075_altered_response_to | 0.84043164 |
| 123 | MP0009763_increased_sensitivity_to | 0.83659489 |
| 124 | MP0001984_abnormal_olfaction | 0.82557268 |
| 125 | MP0006054_spinal_hemorrhage | 0.82076737 |
| 126 | MP0002006_tumorigenesis | 0.81943128 |
| 127 | MP0003828_pulmonary_edema | 0.79783483 |
| 128 | MP0000343_altered_response_to | 0.79781804 |
| 129 | MP0004484_altered_response_of | 0.79457717 |
| 130 | MP0002572_abnormal_emotion/affect_behav | 0.79157349 |
| 131 | MP0005174_abnormal_tail_pigmentation | 0.78052537 |
| 132 | MP0003878_abnormal_ear_physiology | 0.77371289 |
| 133 | MP0005377_hearing/vestibular/ear_phenot | 0.77371289 |
| 134 | MP0008004_abnormal_stomach_pH | 0.77194451 |
| 135 | MP0002928_abnormal_bile_duct | 0.75679169 |
| 136 | MP0000685_abnormal_immune_system | 0.75650309 |
| 137 | MP0002067_abnormal_sensory_capabilities | 0.75159349 |
| 138 | MP0001663_abnormal_digestive_system | 0.74150192 |
| 139 | MP0003718_maternal_effect | 0.73485565 |
| 140 | MP0003879_abnormal_hair_cell | 0.72735699 |
| 141 | MP0001853_heart_inflammation | 0.72699382 |
| 142 | MP0008469_abnormal_protein_level | 0.72365577 |
| 143 | MP0002063_abnormal_learning/memory/cond | 0.72094352 |
| 144 | MP0009765_abnormal_xenobiotic_induced | 0.70630362 |
| 145 | MP0005084_abnormal_gallbladder_morpholo | 0.70054015 |
| 146 | MP0004808_abnormal_hematopoietic_stem | 0.68774217 |
| 147 | MP0005390_skeleton_phenotype | 0.66725579 |
| 148 | MP0005376_homeostasis/metabolism_phenot | 0.66676209 |
| 149 | MP0008874_decreased_physiological_sensi | 0.65707547 |
| 150 | MP0002138_abnormal_hepatobiliary_system | 0.62270892 |
| 151 | MP0003252_abnormal_bile_duct | 0.60476410 |
| 152 | MP0005388_respiratory_system_phenotype | 0.59900492 |
| 153 | MP0002133_abnormal_respiratory_system | 0.59900492 |
| 154 | MP0003806_abnormal_nucleotide_metabolis | 0.59555636 |
| 155 | MP0000249_abnormal_blood_vessel | 0.58410367 |
| 156 | MP0002332_abnormal_exercise_endurance | 0.57546405 |
| 157 | MP0005319_abnormal_enzyme/_coenzyme | 0.56125268 |
| 158 | MP0003795_abnormal_bone_structure | 0.55620024 |
| 159 | MP0003045_fibrosis | 0.54260504 |
| 160 | MP0004130_abnormal_muscle_cell | 0.52059106 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myositis (HP:0100614) | 6.06683891 |
| 2 | Orchitis (HP:0100796) | 5.98611793 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.44479916 |
| 4 | Eczematoid dermatitis (HP:0000976) | 5.31713950 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.74519761 |
| 6 | Gastrointestinal infarctions (HP:0005244) | 4.55801147 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.50489643 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.48913835 |
| 9 | Keratoconjunctivitis sicca (HP:0001097) | 4.44348510 |
| 10 | Parakeratosis (HP:0001036) | 4.37573514 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.34029227 |
| 12 | Keratoconjunctivitis (HP:0001096) | 4.12501301 |
| 13 | Meningitis (HP:0001287) | 3.94508024 |
| 14 | Encephalitis (HP:0002383) | 3.91657814 |
| 15 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.90220303 |
| 16 | Hypochromic microcytic anemia (HP:0004840) | 3.88611590 |
| 17 | Recurrent cutaneous fungal infections (HP:0011370) | 3.81246138 |
| 18 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.81246138 |
| 19 | Obstructive lung disease (HP:0006536) | 3.74500354 |
| 20 | Chronic obstructive pulmonary disease (HP:0006510) | 3.74500354 |
| 21 | T lymphocytopenia (HP:0005403) | 3.67639815 |
| 22 | Spontaneous hematomas (HP:0007420) | 3.65474994 |
| 23 | Abnormality of T cell number (HP:0011839) | 3.53952302 |
| 24 | Gingival bleeding (HP:0000225) | 3.49573404 |
| 25 | Mediastinal lymphadenopathy (HP:0100721) | 3.48475820 |
| 26 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.47223855 |
| 27 | Peritonitis (HP:0002586) | 3.38667484 |
| 28 | Abnormal auditory evoked potentials (HP:0006958) | 3.34203230 |
| 29 | Chest pain (HP:0100749) | 3.30295489 |
| 30 | Stomatitis (HP:0010280) | 3.29466274 |
| 31 | Arterial thrombosis (HP:0004420) | 3.26947094 |
| 32 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.24072561 |
| 33 | Hemoptysis (HP:0002105) | 3.23742306 |
| 34 | Prolonged bleeding time (HP:0003010) | 3.23188573 |
| 35 | Neurofibrillary tangles (HP:0002185) | 3.14107469 |
| 36 | Episodic fever (HP:0001954) | 3.13637134 |
| 37 | Anorexia (HP:0002039) | 3.09361148 |
| 38 | Leukocytosis (HP:0001974) | 3.04102849 |
| 39 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.03164257 |
| 40 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.03164257 |
| 41 | Cerebral hypomyelination (HP:0006808) | 3.00980999 |
| 42 | Hypochromic anemia (HP:0001931) | 3.00050309 |
| 43 | Pulmonary infiltrates (HP:0002113) | 2.96370045 |
| 44 | Cellulitis (HP:0100658) | 2.96324979 |
| 45 | Prolonged neonatal jaundice (HP:0006579) | 2.93742794 |
| 46 | Hypoplastic pelvis (HP:0008839) | 2.89582292 |
| 47 | Pulmonary embolism (HP:0002204) | 2.88918399 |
| 48 | Gingivitis (HP:0000230) | 2.88677163 |
| 49 | Epistaxis (HP:0000421) | 2.81311223 |
| 50 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.81273871 |
| 51 | Recurrent skin infections (HP:0001581) | 2.79687791 |
| 52 | Abnormality of T cells (HP:0002843) | 2.77795985 |
| 53 | Increased IgE level (HP:0003212) | 2.76514998 |
| 54 | Hepatosplenomegaly (HP:0001433) | 2.73462579 |
| 55 | Amyloidosis (HP:0011034) | 2.67496990 |
| 56 | Gangrene (HP:0100758) | 2.66989905 |
| 57 | Recurrent viral infections (HP:0004429) | 2.63625755 |
| 58 | Osteomyelitis (HP:0002754) | 2.60769320 |
| 59 | Spastic tetraparesis (HP:0001285) | 2.59205845 |
| 60 | Microcytic anemia (HP:0001935) | 2.54093120 |
| 61 | Methylmalonic acidemia (HP:0002912) | 2.50821384 |
| 62 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.49925078 |
| 63 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.48567388 |
| 64 | Clumsiness (HP:0002312) | 2.45216155 |
| 65 | Abnormality of the pleura (HP:0002103) | 2.44945627 |
| 66 | Granulocytopenia (HP:0001913) | 2.42358384 |
| 67 | Decreased lacrimation (HP:0000633) | 2.42356983 |
| 68 | Inflammation of the large intestine (HP:0002037) | 2.39489335 |
| 69 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.36786340 |
| 70 | Abnormal ciliary motility (HP:0012262) | 2.35562401 |
| 71 | Sepsis (HP:0100806) | 2.35258981 |
| 72 | Abnormality of the peritoneum (HP:0002585) | 2.35122588 |
| 73 | Increased IgM level (HP:0003496) | 2.30289672 |
| 74 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.29149185 |
| 75 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.29149185 |
| 76 | Abnormality of glycolipid metabolism (HP:0010969) | 2.29149185 |
| 77 | Acute hepatic failure (HP:0006554) | 2.27977297 |
| 78 | Eosinophilia (HP:0001880) | 2.27258055 |
| 79 | Split foot (HP:0001839) | 2.27118994 |
| 80 | Petechiae (HP:0000967) | 2.26549408 |
| 81 | Abnormal hair whorl (HP:0010721) | 2.24987578 |
| 82 | Progressive visual loss (HP:0000529) | 2.24867598 |
| 83 | Hyperventilation (HP:0002883) | 2.22620077 |
| 84 | Panhypogammaglobulinemia (HP:0003139) | 2.22306229 |
| 85 | Gastrointestinal inflammation (HP:0004386) | 2.22225091 |
| 86 | Abnormality of the endocardium (HP:0004306) | 2.20621010 |
| 87 | Focal motor seizures (HP:0011153) | 2.18398751 |
| 88 | Subacute progressive viral hepatitis (HP:0006572) | 2.17987447 |
| 89 | Keratitis (HP:0000491) | 2.17541684 |
| 90 | Axonal loss (HP:0003447) | 2.17419170 |
| 91 | Vertigo (HP:0002321) | 2.15476515 |
| 92 | Basal ganglia calcification (HP:0002135) | 2.15250178 |
| 93 | Poor speech (HP:0002465) | 2.11782924 |
| 94 | Abnormality of T cell physiology (HP:0011840) | 2.11492037 |
| 95 | Methylmalonic aciduria (HP:0012120) | 2.10054128 |
| 96 | Anhidrosis (HP:0000970) | 2.09047895 |
| 97 | Epileptic encephalopathy (HP:0200134) | 2.08995851 |
| 98 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.08488038 |
| 99 | Recurrent fungal infections (HP:0002841) | 2.07969785 |
| 100 | Viral hepatitis (HP:0006562) | 2.07949810 |
| 101 | Pustule (HP:0200039) | 2.07569468 |
| 102 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.06926622 |
| 103 | Thrombophlebitis (HP:0004418) | 2.04979295 |
| 104 | Recurrent pneumonia (HP:0006532) | 2.04926425 |
| 105 | Glomerulopathy (HP:0100820) | 2.04483388 |
| 106 | Abnormal platelet volume (HP:0011876) | 2.02296269 |
| 107 | Increased serum pyruvate (HP:0003542) | 2.01297962 |
| 108 | Abnormality of glycolysis (HP:0004366) | 2.01297962 |
| 109 | Increased cerebral lipofuscin (HP:0011813) | 2.00277787 |
| 110 | Conical tooth (HP:0000698) | 1.99107632 |
| 111 | Skin ulcer (HP:0200042) | 1.98816169 |
| 112 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.97825538 |
| 113 | Peripheral hypomyelination (HP:0007182) | 1.97799212 |
| 114 | Acne (HP:0001061) | 1.96030141 |
| 115 | Recurrent bronchitis (HP:0002837) | 1.95964714 |
| 116 | Cerebral inclusion bodies (HP:0100314) | 1.94171281 |
| 117 | IgM deficiency (HP:0002850) | 1.93746512 |
| 118 | Lymphopenia (HP:0001888) | 1.93547631 |
| 119 | Disinhibition (HP:0000734) | 1.93445812 |
| 120 | Xerostomia (HP:0000217) | 1.92959780 |
| 121 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.92850464 |
| 122 | Urticaria (HP:0001025) | 1.92285736 |
| 123 | Abnormality of eosinophils (HP:0001879) | 1.92090375 |
| 124 | Hypergammaglobulinemia (HP:0010702) | 1.90885105 |
| 125 | Slow saccadic eye movements (HP:0000514) | 1.89848473 |
| 126 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.89596546 |
| 127 | Absent/shortened dynein arms (HP:0200106) | 1.89596546 |
| 128 | Spastic gait (HP:0002064) | 1.88845239 |
| 129 | Polyneuropathy (HP:0001271) | 1.86772334 |
| 130 | Amaurosis fugax (HP:0100576) | 1.85879716 |
| 131 | Sensory axonal neuropathy (HP:0003390) | 1.85083852 |
| 132 | Periodontitis (HP:0000704) | 1.85032158 |
| 133 | Skin rash (HP:0000988) | 1.84504923 |
| 134 | Abnormality of the corticospinal tract (HP:0002492) | 1.83795575 |
| 135 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.83742823 |
| 136 | Difficulty running (HP:0009046) | 1.82394742 |
| 137 | Vacuolated lymphocytes (HP:0001922) | 1.82016687 |
| 138 | Interstitial pulmonary disease (HP:0006530) | 1.81552341 |
| 139 | Leukodystrophy (HP:0002415) | 1.79503751 |
| 140 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.79239790 |
| 141 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.79239790 |
| 142 | Supranuclear gaze palsy (HP:0000605) | 1.79035287 |
| 143 | Rhinitis (HP:0012384) | 1.77143547 |
| 144 | Metaphyseal cupping (HP:0003021) | 1.75906406 |
| 145 | Thickened helices (HP:0000391) | 1.75286896 |
| 146 | Chronic otitis media (HP:0000389) | 1.74447667 |
| 147 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.74386927 |
| 148 | Loss of speech (HP:0002371) | 1.74242170 |
| 149 | CNS hypomyelination (HP:0003429) | 1.73202644 |
| 150 | Autoamputation (HP:0001218) | 1.72823764 |
| 151 | Duplicated collecting system (HP:0000081) | 1.72363936 |
| 152 | Abnormality of the pericardium (HP:0001697) | 1.72216977 |
| 153 | Premature loss of primary teeth (HP:0006323) | 1.70979055 |
| 154 | Hyperphosphatemia (HP:0002905) | 1.70520924 |
| 155 | Colitis (HP:0002583) | 1.70481541 |
| 156 | Ankle clonus (HP:0011448) | 1.69713958 |
| 157 | Stomach cancer (HP:0012126) | 1.69611800 |
| 158 | Poor head control (HP:0002421) | 1.69595560 |
| 159 | Thick nail (HP:0001805) | 1.67813798 |
| 160 | Dysautonomia (HP:0002459) | 1.67009496 |
| 161 | Cheilitis (HP:0100825) | 1.66868354 |
| 162 | Hypoplasia of the uterus (HP:0000013) | 1.64293086 |
| 163 | Pancreatic fibrosis (HP:0100732) | 1.64060316 |
| 164 | 3-Methylglutaconic aciduria (HP:0003535) | 1.63714824 |
| 165 | Progressive neurologic deterioration (HP:0002344) | 1.63583606 |
| 166 | Hypokinesia (HP:0002375) | 1.63314231 |
| 167 | Vasculitis (HP:0002633) | 1.62479906 |
| 168 | Onion bulb formation (HP:0003383) | 1.61926571 |
| 169 | Spastic paraparesis (HP:0002313) | 1.61345152 |
| 170 | Paraparesis (HP:0002385) | 1.60963088 |
| 171 | Optic neuritis (HP:0100653) | 1.60675033 |
| 172 | Retrobulbar optic neuritis (HP:0100654) | 1.60675033 |
| 173 | Progressive inability to walk (HP:0002505) | 1.60525810 |
| 174 | Genital tract atresia (HP:0001827) | 1.59810215 |
| 175 | Vaginal atresia (HP:0000148) | 1.58716500 |
| 176 | Abolished electroretinogram (ERG) (HP:0000550) | 1.56968077 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 3.75553999 |
| 2 | PBK | 3.58207252 |
| 3 | CASK | 3.54457957 |
| 4 | MAP2K3 | 3.36437659 |
| 5 | IRAK4 | 2.98188142 |
| 6 | MAP3K14 | 2.91645001 |
| 7 | EPHB1 | 2.83776325 |
| 8 | RIPK4 | 2.81426127 |
| 9 | OXSR1 | 2.79755366 |
| 10 | MAP4K1 | 2.63542780 |
| 11 | FES | 2.50629221 |
| 12 | GRK6 | 2.45046274 |
| 13 | MAPK15 | 2.43084885 |
| 14 | AKT3 | 2.26136023 |
| 15 | BCR | 2.21149431 |
| 16 | PNCK | 2.06293031 |
| 17 | LIMK1 | 2.00975628 |
| 18 | MST4 | 1.94580444 |
| 19 | PRPF4B | 1.92234804 |
| 20 | BTK | 1.91447951 |
| 21 | TNK2 | 1.91172756 |
| 22 | ZAP70 | 1.90520451 |
| 23 | ERN1 | 1.86658559 |
| 24 | JAK3 | 1.82849776 |
| 25 | BMPR1B | 1.78703669 |
| 26 | FGR | 1.75563202 |
| 27 | SYK | 1.71738916 |
| 28 | TAOK1 | 1.64875967 |
| 29 | JAK2 | 1.63924079 |
| 30 | SIK3 | 1.58222242 |
| 31 | BMPR2 | 1.57991708 |
| 32 | MAP3K6 | 1.57910105 |
| 33 | MAP3K3 | 1.54469239 |
| 34 | PLK2 | 1.51270248 |
| 35 | LYN | 1.51268169 |
| 36 | WNK4 | 1.50957844 |
| 37 | TESK1 | 1.48051318 |
| 38 | TAOK3 | 1.46909904 |
| 39 | BLK | 1.46425360 |
| 40 | SGK494 | 1.39140850 |
| 41 | SGK223 | 1.39140850 |
| 42 | WNK1 | 1.36322296 |
| 43 | PKN1 | 1.35801231 |
| 44 | MAP3K1 | 1.33217612 |
| 45 | TEC | 1.33014795 |
| 46 | MAP3K11 | 1.32520811 |
| 47 | KSR2 | 1.31679352 |
| 48 | IRAK2 | 1.31206503 |
| 49 | IRAK1 | 1.28761909 |
| 50 | MAP3K12 | 1.25372988 |
| 51 | ARAF | 1.21512176 |
| 52 | MAP2K4 | 1.15022539 |
| 53 | TRPM7 | 1.14870441 |
| 54 | CLK1 | 1.12819496 |
| 55 | CSK | 1.09946789 |
| 56 | CSF1R | 1.06544961 |
| 57 | LCK | 1.06296993 |
| 58 | ITK | 1.06077689 |
| 59 | IRAK3 | 1.05724480 |
| 60 | YES1 | 1.03670263 |
| 61 | LRRK2 | 1.03084794 |
| 62 | CCNB1 | 1.03075497 |
| 63 | MAP3K5 | 1.02218185 |
| 64 | FGFR2 | 1.02164092 |
| 65 | IKBKE | 1.01537920 |
| 66 | PIK3CG | 1.00827600 |
| 67 | MAP3K13 | 0.99446996 |
| 68 | NLK | 0.98149915 |
| 69 | ACVR1B | 0.96821750 |
| 70 | KIT | 0.95409477 |
| 71 | CAMK2B | 0.94492556 |
| 72 | FGFR3 | 0.90867721 |
| 73 | DYRK3 | 0.84827798 |
| 74 | BRAF | 0.83528002 |
| 75 | EPHA3 | 0.83159488 |
| 76 | IKBKB | 0.82467279 |
| 77 | STK10 | 0.79269214 |
| 78 | EPHA2 | 0.78880221 |
| 79 | PRKCE | 0.77712825 |
| 80 | TGFBR2 | 0.77375188 |
| 81 | KSR1 | 0.77001968 |
| 82 | RAF1 | 0.76727671 |
| 83 | MAPKAPK5 | 0.76517928 |
| 84 | MARK3 | 0.76115081 |
| 85 | CDK19 | 0.75552763 |
| 86 | PDK1 | 0.74535322 |
| 87 | SGK2 | 0.73249071 |
| 88 | MET | 0.73181663 |
| 89 | STK16 | 0.72491930 |
| 90 | BUB1 | 0.72215677 |
| 91 | PTK6 | 0.71661629 |
| 92 | CAMK2D | 0.70468671 |
| 93 | STK11 | 0.70403879 |
| 94 | ERBB3 | 0.69413845 |
| 95 | MARK2 | 0.68792095 |
| 96 | PIM2 | 0.68150471 |
| 97 | TBK1 | 0.67126491 |
| 98 | FYN | 0.66751830 |
| 99 | MAP2K6 | 0.66210349 |
| 100 | DYRK1B | 0.65111814 |
| 101 | WNK3 | 0.64466138 |
| 102 | TYK2 | 0.63601493 |
| 103 | MAP3K2 | 0.61715490 |
| 104 | TXK | 0.59122520 |
| 105 | STK24 | 0.58600913 |
| 106 | CAMKK2 | 0.58298592 |
| 107 | PRKCQ | 0.56799161 |
| 108 | NEK6 | 0.56206511 |
| 109 | CAMK2A | 0.54762931 |
| 110 | MKNK1 | 0.54489922 |
| 111 | GRK7 | 0.54194935 |
| 112 | MAP2K7 | 0.53271439 |
| 113 | STK4 | 0.52644462 |
| 114 | PIM1 | 0.52220386 |
| 115 | RET | 0.51797936 |
| 116 | GRK5 | 0.51093719 |
| 117 | PRKCD | 0.50793428 |
| 118 | MKNK2 | 0.50491826 |
| 119 | CAMK2G | 0.50326899 |
| 120 | DAPK2 | 0.50099802 |
| 121 | PDPK1 | 0.49407161 |
| 122 | NTRK1 | 0.48262186 |
| 123 | EIF2AK2 | 0.47009615 |
| 124 | EIF2AK3 | 0.46166788 |
| 125 | TAOK2 | 0.45170735 |
| 126 | ZAK | 0.43858141 |
| 127 | RPS6KA5 | 0.43556365 |
| 128 | SGK3 | 0.43365958 |
| 129 | CSNK1A1 | 0.42134752 |
| 130 | HIPK2 | 0.40454368 |
| 131 | JAK1 | 0.37816365 |
| 132 | MAPK7 | 0.37216595 |
| 133 | FRK | 0.37135453 |
| 134 | SGK1 | 0.36747937 |
| 135 | ROCK2 | 0.36165647 |
| 136 | PLK3 | 0.35803093 |
| 137 | PDK3 | 0.34924253 |
| 138 | PDK4 | 0.34924253 |
| 139 | MYLK | 0.33951266 |
| 140 | MAPKAPK2 | 0.33689649 |
| 141 | DYRK1A | 0.32405838 |
| 142 | CSNK1A1L | 0.32063542 |
| 143 | PRKCZ | 0.30914636 |
| 144 | FGFR4 | 0.30804082 |
| 145 | RPS6KA4 | 0.30760563 |
| 146 | PDK2 | 0.30626646 |
| 147 | MAP3K7 | 0.30558586 |
| 148 | PRKD2 | 0.30312026 |
| 149 | EPHA4 | 0.30031192 |
| 150 | PTK2B | 0.27729166 |
| 151 | TNIK | 0.27149167 |
| 152 | ABL2 | 0.27085810 |
| 153 | DYRK2 | 0.26924459 |
| 154 | EGFR | 0.26870027 |
| 155 | PRKG1 | 0.25950240 |
| 156 | ABL1 | 0.25902513 |
| 157 | MATK | 0.25493198 |
| 158 | TESK2 | 0.25169428 |
| 159 | HCK | 0.24777157 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.96269505 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.81074972 |
| 3 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.80383948 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.67516502 |
| 5 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.48890698 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.37893182 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.34130382 |
| 8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.32762770 |
| 9 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.32021083 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.30445658 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 2.29322076 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.26239733 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 2.22622627 |
| 14 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 2.15966548 |
| 15 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.08524465 |
| 16 | Asthma_Homo sapiens_hsa05310 | 2.02570318 |
| 17 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.02109409 |
| 18 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.94079850 |
| 19 | Phagosome_Homo sapiens_hsa04145 | 1.89719140 |
| 20 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.79402573 |
| 21 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.79261750 |
| 22 | Lysosome_Homo sapiens_hsa04142 | 1.77183185 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.76459865 |
| 24 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.72082661 |
| 25 | Proteasome_Homo sapiens_hsa03050 | 1.70206276 |
| 26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.70130535 |
| 27 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.65646729 |
| 28 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.64477444 |
| 29 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.63196435 |
| 30 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.56407360 |
| 31 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.54628419 |
| 32 | Legionellosis_Homo sapiens_hsa05134 | 1.54376777 |
| 33 | Pertussis_Homo sapiens_hsa05133 | 1.54040452 |
| 34 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.53166756 |
| 35 | Protein export_Homo sapiens_hsa03060 | 1.52180795 |
| 36 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.50834744 |
| 37 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.47234098 |
| 38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.44020073 |
| 39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.43501908 |
| 40 | Tuberculosis_Homo sapiens_hsa05152 | 1.42624892 |
| 41 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.39380269 |
| 42 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.32416045 |
| 43 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.30509296 |
| 44 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.30436972 |
| 45 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.26904221 |
| 46 | Platelet activation_Homo sapiens_hsa04611 | 1.26565471 |
| 47 | Hepatitis B_Homo sapiens_hsa05161 | 1.25846973 |
| 48 | Mineral absorption_Homo sapiens_hsa04978 | 1.18992554 |
| 49 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.16517826 |
| 50 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.12176134 |
| 51 | Salmonella infection_Homo sapiens_hsa05132 | 1.11709919 |
| 52 | Malaria_Homo sapiens_hsa05144 | 1.10150149 |
| 53 | Influenza A_Homo sapiens_hsa05164 | 1.10081578 |
| 54 | Phototransduction_Homo sapiens_hsa04744 | 1.09106981 |
| 55 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.08197746 |
| 56 | Viral myocarditis_Homo sapiens_hsa05416 | 1.07283421 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.02596050 |
| 58 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.01497759 |
| 59 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.00686780 |
| 60 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.98034862 |
| 61 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.96029786 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91975291 |
| 63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.90754162 |
| 64 | Apoptosis_Homo sapiens_hsa04210 | 0.85899030 |
| 65 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.85627896 |
| 66 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.82924879 |
| 67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.81136709 |
| 68 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.80115322 |
| 69 | Basal transcription factors_Homo sapiens_hsa03022 | 0.79813516 |
| 70 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.79718106 |
| 71 | Shigellosis_Homo sapiens_hsa05131 | 0.79280049 |
| 72 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.78435862 |
| 73 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.78225287 |
| 74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78018896 |
| 75 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.75202351 |
| 76 | Histidine metabolism_Homo sapiens_hsa00340 | 0.74708078 |
| 77 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.74567427 |
| 78 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.74089882 |
| 79 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72613146 |
| 80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71926463 |
| 81 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.71715900 |
| 82 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.70785714 |
| 83 | Hepatitis C_Homo sapiens_hsa05160 | 0.70095699 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.66809658 |
| 85 | Morphine addiction_Homo sapiens_hsa05032 | 0.66324619 |
| 86 | Endometrial cancer_Homo sapiens_hsa05213 | 0.65758077 |
| 87 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.65649410 |
| 88 | Measles_Homo sapiens_hsa05162 | 0.64201853 |
| 89 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63007730 |
| 90 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.62178839 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59795737 |
| 92 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.58307445 |
| 93 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.57857008 |
| 94 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.57732910 |
| 95 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.56807581 |
| 96 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.56685260 |
| 97 | Amoebiasis_Homo sapiens_hsa05146 | 0.56328483 |
| 98 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.55852096 |
| 99 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.54851390 |
| 100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53996379 |
| 101 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53309199 |
| 102 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52185402 |
| 103 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.51844676 |
| 104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51689958 |
| 105 | Alzheimers disease_Homo sapiens_hsa05010 | 0.51473550 |
| 106 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.51025510 |
| 107 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.50141717 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49782546 |
| 109 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.48688630 |
| 110 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48183726 |
| 111 | Other glycan degradation_Homo sapiens_hsa00511 | 0.47920216 |
| 112 | Prion diseases_Homo sapiens_hsa05020 | 0.47615919 |
| 113 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47460175 |
| 114 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.47408147 |
| 115 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47153831 |
| 116 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47045526 |
| 117 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.45339245 |
| 118 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.44450816 |
| 119 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.43765031 |
| 120 | Insulin resistance_Homo sapiens_hsa04931 | 0.43077582 |
| 121 | Colorectal cancer_Homo sapiens_hsa05210 | 0.42561284 |
| 122 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41709239 |
| 123 | GABAergic synapse_Homo sapiens_hsa04727 | 0.40598893 |
| 124 | Prostate cancer_Homo sapiens_hsa05215 | 0.40467776 |
| 125 | RNA polymerase_Homo sapiens_hsa03020 | 0.40226203 |
| 126 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.38844073 |
| 127 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38229479 |
| 128 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37688202 |
| 129 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37072707 |
| 130 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36894499 |
| 131 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.36274379 |
| 132 | Long-term potentiation_Homo sapiens_hsa04720 | 0.35945010 |
| 133 | Parkinsons disease_Homo sapiens_hsa05012 | 0.35751604 |
| 134 | Nicotine addiction_Homo sapiens_hsa05033 | 0.35366938 |
| 135 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.34245293 |
| 136 | Olfactory transduction_Homo sapiens_hsa04740 | 0.34222607 |
| 137 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.32073219 |
| 138 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.29811552 |
| 139 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.29763810 |
| 140 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.29022102 |
| 141 | Glioma_Homo sapiens_hsa05214 | 0.28816832 |
| 142 | Long-term depression_Homo sapiens_hsa04730 | 0.28804992 |
| 143 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.28584629 |
| 144 | Tight junction_Homo sapiens_hsa04530 | 0.28159903 |
| 145 | Salivary secretion_Homo sapiens_hsa04970 | 0.27889451 |
| 146 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27812306 |
| 147 | Axon guidance_Homo sapiens_hsa04360 | 0.27644022 |

